In addition, the effects of KLF2 in the context of CCM have primarily been studied in whole animal models, with observations of lesion development and vascular morphological defects (Hong et al., 2020; Renz et al., 2015; Zhou et al., 2015, 2016). This evidence concerns the gene KLF2 and cerebral cavernous malformation.